lnfliximab dose intensification in 17-years old patients with Crohn's disease

Abstract

nfliximab is recommended for the treatment of sever, active Crohn's disease (CD) in pediatrie and adolescent patients, who have not responded to conventional therapy. Case report of 17-years old boy with celiac disease and sever CD (A1, L3+L4, B3p) diagnosed at ten ye-ars of age is presented. During the third year of maintenance therapy he lost response to interval of infliximabu infusion. Clinical response was regained after dose intensification by decreasing in interval from eight to four weeks between infliximab infusions. After three months of the intensive treatment with infliximab, patient still remains in clinical remission.

Authors and Affiliations

Małgorzata Sładek

Keywords

Related Articles

Iron absorption - unknown properties of gastric mucins

Introduction: It is accepted, that Fe (III) is being absorbed by the organism after reducing for Fe (II). Objectives: Speciation of iron in compounds with gastric mucins. Materials and methods: "Mucin type II crude from...

Retrospective assessment of qualification criteriaand efficasy of azathioprine therapyfor ulcerative colitis in children - experience of single center

Aim of study: The aim of this study was the assessment of qualifications and efficacy of azathioprine (AZA) treatment in children with ulcerative colitis (UC). Material and methods: 25 patients treated for UC with azathi...

Complications of percutaneous endoscopic gastrostomy (PEG)

Percutaneous Endoscopic Castrostomy is a method widely used for nutritional treatment and gastric decompression. This method is safe. Complications related to it are not danger for patients' life. The aim of this study w...

Suplementy diety w żywieniu dzieci i młodzieży

Suplementy diety spełniają ważną rolę w zmniejszaniu ryzyka zaburzeń stanu zdrowia i wspomagania leczenia chorób. W Polsce odchylenia stanu zdrowia i choroby dietozależne dotyczą około 20% ogółu ludności. Niedobory witam...

Gastrointestinal stromal tumours - rare disease in children or unrecognizable?

Gastrointestinal stromal tumours has so far been diseases very rarely diagnosed in children. We present a case report of two children who were admitted to Department of Paediatrics of Medical University of Silesia. We di...

Download PDF file
  • EP ID EP82767
  • DOI -
  • Views 99
  • Downloads 0

How To Cite

Małgorzata Sładek (2007). lnfliximab dose intensification in 17-years old patients with Crohn's disease. Pediatria Współczesna. Gastroenterologia, Hepatologia i Żywienie Dziecka, 9(3), 219-220. https://europub.co.uk/articles/-A-82767